Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

AbbVie

Status: Completed

Conditions: Crohn's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01464333

P13-170

Details and patient eligibility

About

This study of Humira will be conducted to obtain information on the safety (especially profile of malignant tumors and serious infections) and effectiveness in patients with Crohn's disease who are receiving Humira for a long period of time.

Enrollment: 511 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Crohn's disease indicated for Humira treatment with the recommended dosage regimen
• Patients with no past- or present malignant tumors
• Patients who are not currently receiving Humira

Exclusion criteria

• None.

Trial design

511 participants in 1 patient group

Humira

Description:

Participants who were prescribed Humira per approved prescribing information of Humira in Japan.